Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Proton pump inhibitors and durvalumab in PACIFIC. Local targets link to admitted publications; unresolved targets remain external evidence.
Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial
10.1016/s1470-2045(26)00191-9 · 2026 · External reference
Factors associated with acute esophagitis during radiation therapy for lung cancer
10.1016/j.radonc.2024.110349 · 2024 · External reference
Pretreatment risk model for radiation-induced lymphopenia is associated with adjuvant durvalumab efficacy in patients with unresectable stage III NSCLC
10.1016/j.ijrobp.2026.02.238 · 2026 · External reference
The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: a systematic review and meta-analysis
10.1016/j.ijrobp.2021.07.1695 · 2021 · External reference
Immune checkpoint inhibitor outcomes for patients with non-small-cell lung cancer receiving baseline corticosteroids for palliative versus nonpalliative indications
10.1200/jco.19.00189 · 2019 · External reference
